δ-Opioid receptor agonist SNC80 elicits peripheral antinociception via δ1 and δ2 receptors and activation of the L-arginine/nitric oxide/cyclic GMP pathway

Life Sciences

Volumn 78, Issue 1, 2005, Pages 54-60

  Pacheco, Daniela F ^a   Reis, Gláucia M L ^a   Francischi, Janetti N ^a   Castro, Maria S A ^a   Perez, Andrea C ^a   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Opioid receptor agonist; 1 and 2 opioid receptor antagonists; L arginine NO cGMP pathway; Peripheral antinociception; Prostaglandin E2; SNC80

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 7 BENZYLIDENENALTREXONE; ARGININE; CYCLIC GMP; DELTA OPIATE RECEPTOR; METHYLENE BLUE; NALTRIBEN; NITRIC OXIDE; OPIATE ANTAGONIST; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; RAT; RECEPTOR AFFINITY;

ANALGESICS; ANIMALS; ARGININE; BENZAMIDES; BENZYLIDENE COMPOUNDS; CYCLIC GMP; DINOPROSTONE; ENZYME INHIBITORS; HYPERALGESIA; MALE; NALTREXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PIPERAZINES; RATS; RECEPTORS, OPIOID, DELTA;

ANIMALIA;

EID: 27344432532     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.04.032     Document Type: Article

References (43)

1. K.O. Aley, G. McCarter, and J.D. Levine Nitric oxide signaling in pain and nociceptor sensitization in the rat Journal of Neuroscience 18 1998 7008 7017
2. L.H. Amarante, and I.D.G. Duarte The Kappa-opioid (+/-)-bramazocine elicits peripheral antinociception by activation of the l-arginine/nitric oxide/cyclGMP pathway European Journal of Pharmacology 454 2002 19 23
3. H.N. Bhargava, G.M. Zhao, R.V. House, and P.T. Thomas Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta-1 and delta-2-opioid receptor agonists European Journal of Pharmacology 311 1996 127 132
4. E.J. Bilsky, S.N. Calderon, T. Wang, R.N. Bernstein, P. Davis, V.J. Hruby, R.W. Mcnutt, R.B. Rothman, K.C. Rice, and F. Porreca SNC80, a selective, nonpeptic and systemically active opioid delta agonist Journal of Pharmacology and Experimental Therapeutics 273 1995 359 366
5. I.D. Duarte, I.R. Dos Santos, B.B. Lorenzetti, and S.H. Ferreira Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway European Journal of Pharmacology 217 1992 225 227
6. M. Farias, K.E. Jackson, D. Yoshishige, and J.L. Caffry Cardic enkephalins interrupt vagal bradycardia via delta-2 opioid receptors in sinoatrial node American Journal of Physiology. Heart and Circulatory Physiology 284 2003 1693 1701
7. S.H. Ferreira, I.D.G. Duarte, and B.B. Lorenzetti The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release European Journal of Pharmacology 201 1991 121 122
8. V. Granados-Soto, F.J. Flores-Murrieta, G. Castaneda-Hernandez, and F.J. Lopez-Munoz Evidence for the involvement of nitric oxide in the antinociceptive effect ketorolac European Journal of Pharmacology 277 1995 281 284
9. V. Granados-Soto, M.O. Rufino, L.D. Gomes Lopes, and S.H. Ferreira Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test European Journal of Pharmacology 340 1997 177 180
10. D.L. Hammond, P.E. Stewart, and L. Litteli Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone Journal of Pharmacology and Experimental Therapeutics 274 1995 1317 1324
11. J.S. Heyman, S.A. Mulvaney, H.I. Mosberg, and F. Porreca Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice Brain Research 420 1987 100 108
12. N.K. Jain, C.S. Patil, A. Singh, and S.K. Kulkarni Sildenafil-induced peripheral analgesia and activation of nitric oxide-cyclic GMP pathway Brain Research 909 2001 170 178
13. J. Kamei, Y. Iwamoto, H. Hitosugi, M. Misawa, H. Nagase, and Y. Kasuya Differential mediation of cold water swim stress-induced antinociception by delta-opioid receptor subtypes in diabetic mice Life Science 54 1994 425 430
14. A. Kawabata, Y. Fukuzumi, Y. Fukushima, and H. Takagi Antinociceptive effect of l-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems European Journal of Pharmacology 218 1992 153 158
15. J.R. Lever, M. Stathis, C.M. Kinter, and U. Scheffel In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta-1 subtype Life Sciences 58 1996 331 336
16. A.B. Malmberg, and T.L. Yaksh Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB) Journal of Pharmacology and Experimental Therapeutics 263 1992 264 275
17. A. Mattia, S.C. Farmer, A.E. Takemori, M. Sultana, P.S. Portoghese, H.I. Mosberg, W.D. Bowen, and F. Porreca Spinal opioid delta antinociception in the mouse: mediation by a 5′-NTII-sensitive delta receptor subtype Journal of Pharmacology and Experimental Therapeutics 260 1992 518 525
18. B. Mayer, F. Brunner, and K. Schmidt Inhibition of nitric oxide synthesis by methylene blue Biochemical Pharmacology 45 1993 367 374
19. K.P. Minneman, and L.L. Iversen Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum Nature 262 1976 313 314
20. L. Negri, R.L. Potenza, R. Corsi, and P. Melchiorri Evidence for two subtypes of δ opioid receptors in rat brain European Journal of Pharmacology 192 1991 335 336
21. C.L. Neilan, H. Akil, J.H. Woods, and J.R. Traynor Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists British Journal of Pharmacology 128 1999 556 562
22. R.S. Nelson, and M.R. Eichinger Role of nitric oxide (NO) in pulmonary dysfunction associated with experimental cirrhosis Respiration Physiology 126 2001 65 74
23. 2 opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for δ-opioid receptor heterofeneity Neuroscience 75 1996 917 926
24. N. Nozaki-Taguchi, and T. Yamamoto Involvement of nitric oxide in peripheral antinociception mediated by κ- and δ-opioid receptors Anesthesia and Analgesia 87 1998 388 393
25. C.S. Patil, N.K. Jain, V.P. Singh, and S.K. Kulkarni Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception Indian Journal of Experimental Biology 42 2004 361 367
26. 1 opioid receptor antagonist: 7- Benzylidenenaltrexone European Journal of Pharmacology 218 1992 195 196
27. L.O. Randall, and J.J. Selitto A method for measurement of analgesic activity on inflamed tissues Archives Internationales de Pharmacodynamie et de Therapie 111 1957 409 419
28. R.S. Rapaka, and F. Porreca Development of delta opioid peptides as nonaddicting analgesics Pharmacology Research 8 1991 1 8
29. J. Sarma, S.K. Tandan, S.W. Hajare, and K. Raviprakan Effect of centrally administered nitric oxide modulators in Brewer's yeast-induced nociception in rats Indian Journal of Experimental Biology 38 2000 1123 1128
30. J.E. Schultz, and G.J. Gross Opioids and cardioprotection Pharmacology and Therapeutics 89 2001 123 137
31. M. Sofuoglu, P.S. Portoghese, and A.E. Takemori Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice. Evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257 1991 676 680
32. 1 opioid receptor antagonist in the mouse spinal cord Life Sciences 52 1993 769 775
33. A.M. Sousa, and W.A. Prado The dual effect of a nitric oxide donor in nociception Brain Research 897 2001 9 19
34. C. Stein Peripheral mechanisms of opioid analgesia Anesthesia and Analgesia 76 1993 182 191
35. 4] deltorphin Journal of Pharmacology and Experimental Therapeutics 266 1993 820 828
36. A.E. Takemori, and P.S. Portoghese Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively European Journal of Pharmacology 242 1993 145 150
37. S.N. Thorat, and D.L. Hammond Modulation of nociception by microinjection of delta-1 and delta-2 receptor ligands in the ventromedial medulla the rat Journal of Pharmacology and Experimental Therapeutics 283 1997 1185 1192
38. L. Toll, I.P. Berzetei-Gurske, W.E. Polgar, S.R. Brandt, I.D. Adapa, L. Rodriguez, R.W. Schwartz, D. Haggart, A. O'brien, A. White, Y.J.M. Kenned, K. Craymer, L. Farrington, and J.S. Auh Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications NIDA Research Monograph 178 1998 440 445
39. T. Vanderah, A.E. Takemori, A.M. Sultan, P.S. Portoghese, H.I. Mosberg, V.J. Hruby, R.C. Haaseth, T.O. Matsunaga, and F. Porreca Interaction of [d-Pen2, d-Pen5] enkephalin and [d-Ala2, Glu4] deltorphin with delta-opioid receptor subtypes in vivo European Journal of Pharmacology 252 1994 133 137
40. L.K. Vaughn, W.S. Wire, P. Davis, Y. Shimohigashi, G. Toth, R.J. Knapp, V.J. Hruby, T.F. Burks, and H.I. Yamamura Differentiation between rat brain and mouse vas deferens δ opioid receptor European Journal of Pharmacology 177 1990 99 101
41. G.G. Vivancos, C.A. Parada, and S.H. Ferreira Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues British Journal of Pharmacology 138 2003 1351 1357
42. V. Volke, G. Wegener, E. Vasar, and R. Rosenberg Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo Brain Research 826 1999 303 305
43. S.M. Wildhirt, H. Suzuki, D. Horstman, S. Weismuller, R.R. Dudek, K. Akiyama, and B. Reichart Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction Circulation 96 1997 1616 1623